Literature DB >> 29778980

The influence of early or delayed provision of ankle-foot orthoses on pelvis, hip and knee kinematics in patients with sub-acute stroke: A randomized controlled trial.

Corien D M Nikamp1, Job van der Palen2, Hermie J Hermens3, Johan S Rietman4, Jaap H Buurke3.   

Abstract

BACKGROUND: Compensatory pelvis, hip- and knee movements are reported after stroke to overcome insufficient foot-clearance. Ankle-foot orthoses (AFOs) are often used to improve foot-clearance, but the optimal timing of AFO-provision post-stroke is unknown. Early AFO-provision to prevent foot-drop might decrease the development of compensatory movements, but it is unknown whether timing of AFO-provision affects post-stroke kinematics. RESEARCH QUESTIONS: 1) To compare the effect of AFO-provision at two different points in time (early versus delayed) on frontal pelvis and hip, and sagittal hip and knee kinematics in patients with sub-acute stroke. Effects were assessed after 26 weeks; 2) To study whether possible changes in kinematics or walking speed during the 26-weeks follow-up period differed between both groups.
METHOD: An explorative randomized controlled trial was performed, including unilateral hemiparetic patients maximal six weeks post-stroke with indication for AFO-use. Subjects were randomly assigned to AFO-provision early (at inclusion) or delayed (eight weeks later). 3D gait-analysis with and without AFO was performed in randomized order. Measurements were performed in study-week 1, 9, 17 and 26.
RESULTS: Twenty-six subjects (15 early, 11 delayed) were analyzed. After 26 weeks, no differences in kinematics were found between both groups for any of the joint angles, both for the without and with AFO-condition. Changes in kinematics during the 26-weeks follow-up period did not differ between both groups for any of the joint angles during walking without AFO. Significant differences in changes in walking speed during the 26-weeks follow-up were found (p = 0.034), corresponding to the first eight weeks after AFO-provision. SIGNIFICANCE: Results indicate that early or delayed AFO-use post-stroke does not influence pelvis, hip and knee movements after 26 weeks, despite that AFO-use properly corrected drop-foot. AFOs should be provided to improve drop-foot post-stroke, but not with the intention to influence development of compensatory patterns around pelvis and hip.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ankle-foot orthosis, stroke rehabilitation; Compensatory movement patterns; Gait-analysis; Pelvis, hip and knee kinematics; Randomized controlled trial

Mesh:

Year:  2018        PMID: 29778980     DOI: 10.1016/j.gaitpost.2018.05.012

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  4 in total

1.  The effect of ankle-foot orthoses on fall/near fall incidence in patients with (sub-)acute stroke: A randomized controlled trial.

Authors:  Corien D M Nikamp; Marte S H Hobbelink; Job van der Palen; Hermie J Hermens; Johan S Rietman; Jaap H Buurke
Journal:  PLoS One       Date:  2019-03-12       Impact factor: 3.240

2.  The long-term effects of an implantable drop foot stimulator on gait in hemiparetic patients.

Authors:  Agnes Sturma; Othmar Schuhfried; Timothy Hasenoehrl; Clemens Ambrozy; Stefan Salminger; Laura A Hruby; Johannes A Mayer; Kirsten Götz-Neumann; Richard Crevenna; Michaela M Pinter; Oskar C Aszmann
Journal:  PLoS One       Date:  2019-04-17       Impact factor: 3.240

3.  Effects of wearable ankle robotics for stair and over-ground training on sub-acute stroke: a randomized controlled trial.

Authors:  Ling-Fung Yeung; Cathy C Y Lau; Charles W K Lai; Yannie O Y Soo; Man-Lok Chan; Raymond K Y Tong
Journal:  J Neuroeng Rehabil       Date:  2021-01-29       Impact factor: 4.262

4.  Anterior or Posterior Ankle Foot Orthoses for Ankle Spasticity: Which One Is Better?

Authors:  Carl P C Chen; Areerat Suputtitada; Watchara Chatkungwanson; Kittikorn Seehaboot
Journal:  Brain Sci       Date:  2022-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.